XNYS
GMRE
Market cap514mUSD
Apr 25, Last price
7.69USD
1D
0.26%
1Q
-3.15%
Jan 2017
-13.79%
IPO
-89.32%
Name
Global Medical REIT Inc
Chart & Performance
Profile
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 138,410 -1.79% | 140,934 2.66% | 137,283 18.41% | |||||||
Cost of revenue | 21,278 | 103,070 | 41,733 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 117,132 | 37,864 | 95,550 | |||||||
NOPBT Margin | 84.63% | 26.87% | 69.60% | |||||||
Operating Taxes | 25,230 | |||||||||
Tax Rate | 26.41% | |||||||||
NOPAT | 117,132 | 37,864 | 70,320 | |||||||
Net income | 6,633 -67.82% | 20,612 -493.81% | (5,234) 152.36% | |||||||
Dividends | (65,690) | (64,847) | (64,242) | |||||||
Dividend yield | 12.91% | 8.91% | 10.35% | |||||||
Proceeds from repurchase of equity | 10,896 | 9,896 | ||||||||
BB yield | -2.14% | -1.59% | ||||||||
Debt | ||||||||||
Debt current | 631,732 | 405 | 636,447 | |||||||
Long-term debt | 29,321 | 626,187 | 68,207 | |||||||
Deferred revenue | 4,441 | |||||||||
Other long-term liabilities | 7,260 | 13,380 | 20,437 | |||||||
Net debt | 652,172 | 600,189 | 665,933 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 70,046 | 68,440 | 76,541 | |||||||
CAPEX | (156,201) | |||||||||
Cash from investing activities | (45,942) | 67,616 | (137,252) | |||||||
Cash from financing activities | (21,886) | (143,787) | 62,407 | |||||||
FCF | 163,628 | (13,490) | 40,359 | |||||||
Balance | ||||||||||
Cash | 6,815 | 26,403 | 4,016 | |||||||
Long term investments | 2,066 | 34,705 | ||||||||
Excess cash | 1,960 | 19,356 | 31,857 | |||||||
Stockholders' equity | (178,307) | (116,604) | (72,926) | |||||||
Invested Capital | 1,395,075 | 1,354,710 | 1,440,988 | |||||||
ROIC | 8.52% | 2.71% | 5.10% | |||||||
ROCE | 9.63% | 3.06% | 7.01% | |||||||
EV | ||||||||||
Common stock shares outstanding | 65,936 | 65,550 | 65,462 | |||||||
Price | 7.72 -30.45% | 11.10 17.09% | 9.48 -46.59% | |||||||
Market cap | 509,026 -30.04% | 727,605 17.25% | 620,580 -42.34% | |||||||
EV | 1,257,947 | 1,424,983 | 1,377,553 | |||||||
EBITDA | 172,045 | 96,873 | 153,212 | |||||||
EV/EBITDA | 7.31 | 14.71 | 8.99 | |||||||
Interest | 28,689 | 30,893 | 25,230 | |||||||
Interest/NOPBT | 24.49% | 81.59% | 26.41% |